Compartir
Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (en Inglés)
U. S. Department of Commerce
(Autor)
·
Createspace Independent Publishing Platform
· Tapa Blanda
Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (en Inglés) - U. S. Department of Commerce
26,00 €
28,89 €
Ahorras: 2,89 €
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 24 de Julio y el
Miércoles 07 de Agosto.
Lo recibirás en cualquier lugar de España entre 1 y 5 días hábiles luego del envío.
Reseña del libro "Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (en Inglés)"
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examined the drug price regulatory systems of 11 OECD countries. A quantitative analysis of prices, revenues, and R&D effects based on available data was also conducted for nine OECD countries. For reasons explained in the report, two of these nine countries were excluded from further consideration. The results from the remaining six countries were then extrapolated to the total patented markets of five additional OECD countries. Thus, the final estimates of the impact of price controls on R&D and innovation are based on an analysis of 11 OECD countries.
